(22UA) BioNTech SE - Performance 24.8% in 12m
22UA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-6.42%
#36 in Peer-Group
Rel. Strength
73.92%
#1999 in Stock-Universe
Total Return 12m
24.82%
#42 in Peer-Group
Total Return 5y
25.84%
#30 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 7.14 |
| High / Low | EUR |
|---|---|
| 52 Week High | 122.90 EUR |
| 52 Week Low | 71.80 EUR |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 84.09 |
| Buy/Sell Signal +-5 | -0.94 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: 22UA (24.8%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: 22UA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for 22UA
| Total Return (including Dividends) | 22UA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.27% | 3.15% | 4.01% |
| 3 Months | 16.44% | 17.08% | 17.14% |
| 12 Months | 24.82% | -11.14% | 13.46% |
| 5 Years | 25.84% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | 22UA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 64.4% | 52.1% | 90.3% |
| 3 Months | 36.7% | 79.4% | 97.5% |
| 12 Months | 6.4% | -87.4% | 46.4% |
| 5 Years | -49.5% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.50 | 0.12% | -0.71% |
| 3 Month | %th43.50 | -0.54% | -0.60% |
| 12 Month | %th80.00 | 40.47% | 10.01% |
| 5 Years | %th88.00 | 77.06% | -33.93% |
FAQs
Does BioNTech SE (22UA) outperform the market?
Yes,
over the last 12 months 22UA made 24.82%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months 22UA made 16.44%, while XBI made 17.08%.
Performance Comparison 22UA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
22UA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.4% | -0.7% | -23.5% | 11% |
| US NASDAQ 100 | QQQ | 2.5% | -0.9% | -25.5% | 12% |
| German DAX 40 | DAX | 2.1% | 2.1% | -35.6% | -5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.2% | -1.3% | -28% | 6% |
| Hongkong Hang Seng | HSI | 1.5% | 0.4% | -45.5% | -10% |
| India NIFTY 50 | INDA | 3.8% | 4.1% | -24% | 28% |
| Brasil Bovespa | EWZ | 6.6% | 3.9% | -38.5% | 23% |
22UA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.8% | 1.6% | -26.8% | 1% |
| Consumer Discretionary | XLY | 1.5% | -0.1% | -15.8% | 7% |
| Consumer Staples | XLP | 4.5% | 3.4% | -22.6% | 17% |
| Energy | XLE | -0.5% | -0.9% | -15.9% | 23% |
| Financial | XLF | 3.9% | 0.6% | -25.8% | -1% |
| Health Care | XLV | 2.3% | 3.2% | -12% | 32% |
| Industrial | XLI | 2% | -1.2% | -29.3% | 1% |
| Materials | XLB | 1.7% | -1.2% | -24.1% | 21% |
| Real Estate | XLRE | 2.7% | 3.4% | -22% | 17% |
| Technology | XLK | 2.5% | -3.4% | -28.6% | 14% |
| Utilities | XLU | 2.3% | 0.7% | -27.5% | 5% |
| Aerospace & Defense | XAR | 1.8% | -3.6% | -43.5% | -24% |
| Biotech | XBI | -1.2% | 0.1% | -13.3% | 36% |
| Homebuilder | XHB | -0.7% | -5.5% | -16.9% | 26% |
| Retail | XRT | 2.5% | 0% | -18.7% | 18% |
22UA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.8% | -0.03% | -9.59% | 29% |
| Natural Gas | UNG | 4.1% | 9.7% | 2.5% | 27% |
| Gold | GLD | 2.3% | 3% | -41.4% | -14% |
| Silver | SLV | -1.9% | -3% | -45.5% | 3% |
| Copper | CPER | -7.9% | -11.7% | -43% | 1% |
22UA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.3% | 3.3% | -18.2% | 29% |
| iShares High Yield Corp. Bond | HYG | 3% | 2.1% | -20.5% | 16% |